KPWS
IBRX icon

Kestra Private Wealth Services’s ImmunityBio IBRX Stock Holding History

Kestra Private Wealth Services’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207K Hold
23,698
– – ﹤0.01% 1686
2026
Q1 		$182K Buy
23,698
+589
+3% +$4.03K ﹤0.01% 1654
2025
Q4 		$45.8K Sell
23,109
-900
-4% -$2.04K ﹤0.01% 1685
2025
Q3 		$59.1K Hold
24,009
– – ﹤0.01% 1630
2025
Q2 		$63.4K Sell
24,009
-5,800
-19% -$15.6K ﹤0.01% 1572
2025
Q1 		$89.7K Hold
29,809
– – ﹤0.01% 1457
2024
Q4 		$76.3K Sell
29,809
-2,900
-9% -$12.1K ﹤0.01% 1371
2024
Q3 		$122K Buy
32,709
+6,074
+23% +$28.1K ﹤0.01% 1306
2024
Q2 		$168K Buy
+26,635
New +$176K ﹤0.01% 1253

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kestra Private Wealth Services's IBRX Position: Q2 2026 in Review

Kestra Private Wealth Services held its ImmunityBio (IBRX) position steady in Q2 2026 at 23,698 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #1686.

Kestra Private Wealth Services first reported a position in IBRX in Q2 2024 and has held it in 9 quarters since. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Kestra Private Wealth Services held 23,698 shares of ImmunityBio worth $207K as of Q2 2026.
  • Kestra Private Wealth Services left its ImmunityBio share count unchanged in Q2 2026.
  • ImmunityBio made up ﹤0.01% of Kestra Private Wealth Services's portfolio in Q2 2026, its #1686 holding.
  • Kestra Private Wealth Services first reported a position in ImmunityBio in Q2 2024 and has held it in 9 quarters since.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Kestra Private Wealth Services's 13F filing for Q2 2026, filed 28 Jul 2026.